Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2011 (2011), Article ID 240340, 6 pages
http://dx.doi.org/10.1155/2011/240340
Clinical Study

Pre-Treatment Deep Curettage Can Significantly Reduce Tumour Thickness in Thick Basal Cell Carcinoma While Maintaining a Favourable Cosmetic Outcome When Used in Combination with Topical Photodynamic Therapy

1Department of Dermatology, St. Olav's University Hospital HF, Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway
2Dermatology Unit, Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway
3Department of Orthopaedics, St. Olav's University Hospital HF and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway

Received 20 June 2011; Revised 30 August 2011; Accepted 30 August 2011

Academic Editor: M. Lebwohl

Copyright © 2011 Eidi Christensen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Miller and M. A. Weinstock, “Nonmelanoma skin cancer in the United States: incidence,” Journal of the American Academy of Dermatology, vol. 30, no. 5, part 1, pp. 774–778, 1994. View at Google Scholar · View at Scopus
  2. D. H. Brewster, L. A. Bhatti, J. H. C. Inglis, E. R. Nairn, and V. R. Doherty, “Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003,” British Journal of Dermatology, vol. 156, no. 6, pp. 1295–1300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Miller, “Biology of basal cell carcinoma (part I),” Journal of the American Academy of Dermatology, vol. 24, no. 1, pp. 1–13, 1991. View at Google Scholar · View at Scopus
  4. A. N. Crowson, “Basal cell carcinoma: biology, morphology and clinical implications,” Modern Pathology, vol. 19, supplement 2, pp. S127–S147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. F. J. Bath-Hextall, W. Perkins, J. Bong, and H. C. Williams, “Interventions for basal cell carcinoma of the skin,” Cochrane Database of Systematic Reviews, no. 1, p. CD003412, 2007. View at Google Scholar · View at Scopus
  6. R. I. Ceilley and J. Q. del Rosso, “Current modalities and new advances in the treatment of basal cell carcinoma,” International Journal of Dermatology, vol. 45, no. 5, pp. 489–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. Szeimies, “Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma,” Dermatologic Clinics, vol. 25, no. 1, pp. 89–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Lien and V. K. Sondak, “Nonsurgical treatment options for basal cell carcinoma,” Journal of Skin Cancer, vol. 2011, Article ID 571734, 6 pages, 2011. View at Publisher · View at Google Scholar
  9. Q. Peng, T. Warloe, K. Berg et al., “5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges,” Cancer, vol. 79, no. 12, pp. 2282–2308, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. L. E. Rhodes, M. A. de Rie, R. Leifsdottir et al., “Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma,” Archives of Dermatology, vol. 143, no. 9, pp. 1131–1136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Basset-Seguin, S. H. Ibbotson, L. Emtestam et al., “Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial,” European Journal of Dermatology, vol. 18, no. 5, pp. 547–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Christensen, E. Skogvoll, T. Viset, T. Warloe, and S. Sundstrøm, “Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 1, pp. 58–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. S. Souza, L. B. A. Felicio, J. Ferreira et al., “Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer,” Photodiagnosis and Photodynamic Therapy, vol. 6, no. 3-4, pp. 207–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. R. Braathen, R. M. Szeimies, N. Basset-Seguin et al., “Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus,” Journal of the American Academy of Dermatology, vol. 56, no. 1, pp. 125–143, 2007. View at Publisher · View at Google Scholar
  15. C. A. Morton, K. E. McKenna, and L. E. Rhodes, “Guidelines for topical photodynamic therapy: update,” British Journal of Dermatology, vol. 159, no. 6, pp. 1245–1266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Peng, A. M. Soler, T. Warloe, J. M. Nesland, and K. E. Giercksky, “Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate,” Journal of Photochemistry and Photobiology B, vol. 62, no. 3, pp. 140–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ahmadi, P. A. McCarron, R. F. Donnelly, A. D. Woolfson, and K. McKeena, “Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study,” Experimental Dermatology, vol. 13, no. 7, pp. 445–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sandberg, C. B. Halldin, M. B. Ericson, O. Larkö, A. L. Krogstad, and A. M. Wennberg, “Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo,” British Journal of Dermatology, vol. 159, no. 5, pp. 1170–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Warloe, H. Heyerdahl, and K. E. Giercksky, Curettage and topical ALA-based photodynamic therapy for nodular basal cell carcinoma, Ph.D. thesis, University of Oslo, Oslo, Norway, 1995.
  20. M. R. T. M. Thissen, C. A. Schroeter, and H. A. M. Neumann, “Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique,” British Journal of Dermatology, vol. 142, no. 2, pp. 338–339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Christensen, T. Warloe, S. Kroon et al., “Guidelines for practical use of MAL-PDT in non-melanoma skin cancer,” Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 5, pp. 505–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. E. Rhodes, M. de Rie, Y. Enström et al., “Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial,” Archives of Dermatology, vol. 140, no. 1, pp. 17–23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Mosterd, M. R. T. M. Thissen, P. Nelemans et al., “Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial,” British Journal of Dermatology, vol. 159, no. 4, pp. 864–870, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Soler, T. Warloe, A. Berner, and K. E. Giercksky, “A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage,” British Journal of Dermatology, vol. 145, no. 3, pp. 467–471, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Vinciullo, T. Elliott, D. Francis et al., “Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma,” British Journal of Dermatology, vol. 152, no. 4, pp. 765–772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Scrivener, E. Grosshans, and B. Cribier, “Variations of basal cell carcinomas according to gender, age, location and histopathological subtype,” British Journal of Dermatology, vol. 147, no. 1, pp. 41–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Braun, F. Klumb, C. Girard et al., “Three-dimensional reconstruction of basal cell carcinomas,” Dermatologic Surgery, vol. 31, no. 5, pp. 562–566, 2005. View at Google Scholar · View at Scopus
  28. E. Christensen, P. Mjønes, O. A. Foss et al., “Pre-treatment evaluation of basal cell carcinoma for photodynamic therapy: comparative measurement of tumour thickness in punch biopsy and excision specimens,” Acta Dermato-Venereologica, vol. 91, no. 6, pp. 651–654, 2011. View at Publisher · View at Google Scholar
  29. C. Curson and D. Weedon, “Spontaneous regression in basal cell carcinomas,” Journal of Cutaneous Pathology, vol. 6, no. 5, pp. 432–437, 1979. View at Google Scholar · View at Scopus
  30. M. J. Hunt, G. M. Halliday, D. Weedon, B. E. Cooke, and R. S. Barnetson, “Regression in basal cell carcinoma: an immunohistochemical analysis,” British Journal of Dermatology, vol. 130, no. 1, pp. 1–8, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Swetter, J. C. Boldrick, P. Pierre, P. Wong, and B. M. Egbert, “Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens,” Journal of Cutaneous Pathology, vol. 30, no. 2, pp. 139–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. W. E. McDaniel, “Therapy for basal cell epitheliomas by curettage only. Further study,” Archives of Dermatology, vol. 119, no. 11, pp. 901–903, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Reymann, “15 years' experience with treatment of basal cell carcinomas of the skin with curettage,” Acta Dermato-Venereologica, vol. 65, supplement 120, pp. 56–59, 1985. View at Google Scholar
  34. J. O. Barlow, M. J. Zalla, A. Kyle, D. J. DiCaudo, K. K. Lim, and J. A. Yiannias, “Treatment of basal cell carcinoma with curettage alone,” Journal of the American Academy of Dermatology, vol. 54, no. 6, pp. 1039–1045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. H. Jih, P. M. Friedman, L. H. Goldberg, and A. Kimyai-Asadi, “Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study,” Dermatologic Surgery, vol. 31, no. 1, pp. 10–15, 2005. View at Google Scholar · View at Scopus
  36. P. Foley, M. Freeman, A. Menter et al., “Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies,” International Journal of Dermatology, vol. 48, no. 11, pp. 1236–1245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Fantini, A. Greco, C. del Giovane et al., “Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 8, pp. 896–901, 2011. View at Publisher · View at Google Scholar